Our mission is to devise new imaging approaches to address unanswered questions about the role of oxygen in cancer.
We are an international team combining physicists, engineers, chemists, and molecular biologists who work at the clinical interface. Our new imaging approaches predominantly use visible and near infrared light, to avoid ionising radiation and access relatively low cost devices.
We achieve developments in this area through a combination of: modelling, to understand the interactions between light and tissue; and innovative instrument design, integrating new technologies to enable spectral imaging. By applying such developments to preclinical disease models and ultimately in patients, we aim to better understand the role of oxygen and oxidative stress in cancer progression, from early development through to treatment resistance.